PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.2018.37.3.248.corr2018374426-426Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248-256]Eun Joo Song, Kye Hwa Jeong, Young Ae Yang, Jeong-Hoon Lim, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Parkhttp://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-04-18.pdf, http://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-04-18.pdf
Kidney Research and Clinical Practice10.23876/j.krcp.2018.37.3.2482018373248-256Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathyEun Joo Song, Kye Hwa Jeong, Young Ae Yang, Jeong-Hoon Lim, Hee-Yeon Jung, Ji-Young Choi, Jang-Hee Cho, Chan-Duck Kim, Yong-Lim Kim, Sun-Hee Parkhttp://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-03-248.pdf, http://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-03-248.pdf
Kidney Research and Clinical Practice10.23876/j.krcp.2018.37.3.1812018373181-182Anti-phospholipase A2 receptor antibodies in membranous nephropathySangho Leehttp://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-03-181.pdf, http://pdf.medrang.co.kr/KRCP2/2018/037/KRCP037-03-181.pdf
BMC Nephrology10.1186/s12882-020-01856-z2020211Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathyMaxime Teisseyre, Hélène Perrochia, Pascal Reboul, Sylvain Cariou, Sophie Renaud, Cédric Aglae, Olivier Morannehttps://link.springer.com/content/pdf/10.1186/s12882-020-01856-z.pdf, https://link.springer.com/article/10.1186/s12882-020-01856-z/fulltext.html, https://link.springer.com/content/pdf/10.1186/s12882-020-01856-z.pdf
Reactions Weekly10.1007/s40278-022-15076-4202219061186-186Entecavir/peginterferon/tacrolimushttps://link.springer.com/content/pdf/10.1007/s40278-022-15076-4.pdf, https://link.springer.com/article/10.1007/s40278-022-15076-4/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-022-15076-4.pdf
Frontiers in Immunology10.3389/fimmu.2022.905930202213Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous NephropathyLei Dong, Yue-qiang Li, Shui-ming Guo, Gang Xu, Wang Wei, Min Hanhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.905930/full
CEN Case Reports10.1007/s13730-018-0304-7201871101-106Membranous nephropathy associated with pregnancy: an anti-phospholipase A2 receptor antibody-positive case reportEiichiro Uchino, Daisuke Takada, Haruta Mogami, Takeshi Matsubara, Tatsuo Tsukamoto, Motoko Yanagitahttp://link.springer.com/article/10.1007/s13730-018-0304-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13730-018-0304-7.pdf, http://link.springer.com/content/pdf/10.1007/s13730-018-0304-7.pdf
Advances in Nephropathy10.5772/intechopen.789552018Antibodies Against M-Type Phospholipase A2 Receptor (PLA2R) in Patients with Primary Membranous Nephropathy and Lupus Nephritis Class V: A ReviewRosa M. Viero, Bruno M. Miamoto, Vanessa dos S. Silva, Daniela C. dos Santoshttp://www.intechopen.com/download/pdf/62188
Reactions Weekly10.1007/s40278-021-95785-1202118551109-109Cemiplimabhttps://link.springer.com/content/pdf/10.1007/s40278-021-95785-1.pdf, https://link.springer.com/article/10.1007/s40278-021-95785-1/fulltext.html, https://link.springer.com/content/pdf/10.1007/s40278-021-95785-1.pdf
Romanian Journal of Internal Medicine10.2478/rjim-2018-00442019572141-150Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy – a retrospective cohort studySimella Provatopoulou, Dimitra Kalavrizioti, Maria Stangou, Maria-Nikoleta Kouri, Pantellitsa Kalliakmani, Marios Papasotiriou, Evangelos Papachristou, Dimitrios S. Goumenos, Aikaterini Papagiannihttps://content.sciendo.com/view/journals/rjim/57/2/article-p141.xml, https://www.sciendo.com/pdf/10.2478/rjim-2018-0044